PMC:7787218 / 19978-20313 JSONTXT

{"project":"LitCovid-PubTator","denotations":[{"id":"318","span":{"begin":228,"end":236},"obj":"Chemical"},{"id":"319","span":{"begin":241,"end":255},"obj":"Chemical"},{"id":"320","span":{"begin":258,"end":264},"obj":"Chemical"},{"id":"321","span":{"begin":329,"end":334},"obj":"Chemical"}],"attributes":[{"id":"A318","pred":"tao:has_database_id","subj":"318","obj":"MESH:C000595210"},{"id":"A319","pred":"tao:has_database_id","subj":"319","obj":"MESH:D011136"},{"id":"A321","pred":"tao:has_database_id","subj":"321","obj":"MESH:D008055"}],"namespaces":[{"prefix":"Tax","uri":"https://www.ncbi.nlm.nih.gov/taxonomy/"},{"prefix":"MESH","uri":"https://id.nlm.nih.gov/mesh/"},{"prefix":"Gene","uri":"https://www.ncbi.nlm.nih.gov/gene/"},{"prefix":"CVCL","uri":"https://web.expasy.org/cellosaurus/CVCL_"}],"text":"* Phase information was current as of December 21, 2020. In all cases, the placebo was normal saline.\n† Bold entries are excipients potentially related to vaccine reaction that may be cross-reactive to other excipients (e.g., PEG 2000 and polysorbate 80). SM-102, a component of the Moderna vaccine, is a proprietary ionizable lipid."}

{"project":"LitCovid-sentences","denotations":[{"id":"T93","span":{"begin":0,"end":57},"obj":"Sentence"},{"id":"T94","span":{"begin":58,"end":102},"obj":"Sentence"},{"id":"T95","span":{"begin":103,"end":257},"obj":"Sentence"},{"id":"T96","span":{"begin":258,"end":335},"obj":"Sentence"}],"namespaces":[{"prefix":"_base","uri":"http://pubannotation.org/ontology/tao.owl#"}],"text":"* Phase information was current as of December 21, 2020. In all cases, the placebo was normal saline.\n† Bold entries are excipients potentially related to vaccine reaction that may be cross-reactive to other excipients (e.g., PEG 2000 and polysorbate 80). SM-102, a component of the Moderna vaccine, is a proprietary ionizable lipid."}